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The endo-diastereo and  enantioselective 1,3-dipolar cycloaddition
of azomethine ylides and electrophilic alkenes is efficiently
catalysed by chiral phosphoramidite-silver(I) perchlorate
complexes. The reaction allows the presence of different type of
substituents in the 1,3-dipole and can be applied to the synthesis of
enantiomerically enriched highly substituted prolines. This
methodology has been applied to the total synthesis of inhibitors of
the hepatitis C virus polymerase.  
 The computational studies support a two step mechanism 
predicting exactly the experimental results and the origin of the 
both diastereo- and enantioselections as well as a rational 
explanation concerning the different reaction rates observed for 
some substrates. 
 (© WILEY-VCH Verlag GmbH & Co. KGaA, 69451 
Weinheim, Germany, 2009) 
 
Introduction 
The catalytic enantioselective 1,3-dipolar cycloaddition (1,3-
DC),[ 1 ] involving azomethine ylides and electrophilic alkenes, 
constitutes a straightforward transformation[2] in the generation of 
up to four stereogenic centres in only one step. The high diastereo- 
and enantioselective control allows to obtain enantiomerically 
substituted proline derivatives,[3] which are important structures in 
scientific areas such as biology (peptide design),[3, 4 ] medicine 
(antiviral,[ 5 ] neuroexcitatory,[ 6 ] and insecticide agents[ 7 ]) and 
organic chemistry (organocatalysts).[8] 
Grigg et al. pioneered the catalytic enantioselective 1,3-DC 
employing large amounts of chiral cobalt complexes.9 In 2002, the 
enantioselective synthesis of this enantiomerically pure prolines 
through the 1,3-DC between azomethine ylides and  electron-
deficient alkenes was successfully achieved employing a chiral 
bisphosphine-silver(I) complexes in substoichiometric amounts.[10] 
Later on many other contributions regarding the employment of the 
chiral complexes formed by silver(I),[10,11] copper(I),[12] zinc(II),[13] 
nickel(II),[ 14 ] and calcium(II)[ 15 ] were reported. Recently, 
organocatalyzed processes[ 16 ] has been employed but finding 
notable structural restrictions, for instance, they need very 
activated imino-malonates as 1,3-dipole precursors, and α,β-
unsaturated aldehydes or ketones as dipolarophiles.  
Silver and copper complexes are the most employed catalysts 
generating excellent enantioselections in the resulting proline 
derivatives. Whilst a chiral copper(I)-catalyzed process occurs with 
high exo-diastereoselection, the silver(I)-catalyzed reaction gave 
the corresponding endo-adducts. In general, chiral bidentate 
ligands such as diphosphines, aminophosphines, sulfur-containing 
phosphines, bisoxazolines and diimines are used as chiral ligand. A 
common problem in these reactions is their sensitivity to the 
presence of very bulky substituents in the 1,3-dipole and in the 
dipolarophile as well. 
In a previous communication[11c] we reported the first 
enantioselective 1,3-DC of azomethine ylides and alkenes using 
monodentate ligands such as chiral phosphoramidites together to 
AgClO4. The main advantages of this type of catalysts is its 
availability, the easy modulation of the two stereogenic elements of 
the chiral ligand, and the use of α-branched imino esters. All these 
aspects are combined to obtain high enantioselectivities of the 
resulting pyrrolidines. In this work we describe the full account of 
this reaction, and a DFT-based study focused on the elucidation of 
the origin of regio-, diastereo- and enantioselectivity observed in 
the process.[17] 
Results and Discussion 
Although chiral phosphoramidites 1, 2, and 3[18] (Figure 1) have 
been extensively used in asymmetric hydrogenations[19] and many 
other transformations such as allylations, Michael-type additions, 
and carbonyl addition reactions,[19b] they were not previously used 
as ligands in 1,3-DC between azomethine ylides and dipolarophiles. 
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Figure 1. Phosphoramidites 1-3. 
Initially, the optimization of the reaction was carried out at room 
temperature employing tert-butyl acrylate as dipolarophile and 
methyl or isopropyl N-benzylideneimino glycinates 4aa or 4ab, 
respectively. Employing 5 mol-% of catalyst, formed by in situ 
addition of a 1:1 mixture of phosphoramidite and the silver salt 
(Scheme 1, and Table 1) was employed in the presence of an 
organic base (5 mol-%). The catalysts formed by AgClO4 (5 mol-
%) and ligands (Sa)-1 or 2 (5 mol-%) and triethylamine as base (5 
mol-%) gave lower er of cycloadduct 5aa than with the catalyst 
system consisting of  a 1:1 mixture of AgClO4 (5 mol-%) and 
(Sa,R,R)-3 (5 mol-%) (Table 1, entries 1-3). When a 2:1 mixture of 
AgClO4:(Sa,R,R)-3 (5 mol-%) was used instead the er was also 
lower than the result described for the 1:1 mixture (Table 1, entry 
4). Other different silver salts such as acetate, triflate, fluoride, or 
tetrafluoroborate did not improve the enantiomeric ratio generated 
by AgClO4 (Table 1, entries 5-8). 
Ph N CO2R
4aa; R = Me
4ab; R = iPr
4ac; R = tBu
tBuO2C
N
H
tBuO2C
Ph CO2R
endo-5a
AgX (5 mol-%)
ligand (5 mol-%)
base (5 mol-%)
toluene, T [º C]
8-16 h
+
 
Scheme 1 
Then, the temperature, the used base and the ester group nature 
were studied in order to improve the enantioselectivity of the 
process. Thus, the reaction of 4aa run at 0 or at −20 ºC with Et3N  
improved the enantioselection (Table 1, compare entries 3, 9 and 
10). Other bases, such as DIPEA or DABCO (5 mol-%) were also 
attempted at −20 ºC, obtaining better enantioselections (96:4 er) 
with DABCO (Table 1, compare entries 10, 12 and 13). Under 
these conditions monophos ligand (Sa)-1 was also employed 
obtaining lower chiral induction than the reaction done with ligand 
3 (Table 1, compare entries 10 and 11). In the other side, the 
substitution of the methyl by an isopropyl group at the iminoester 
(Table 1, entries 15-22) was very satisfactory in terms of 
enantioselection (>99:1) and conversions of the product 5ab, when 
the reaction was performed at −20 ºC independently of the used 
base (Table 1 compare entries 10 with 16 and 13 with 17). The best 
reaction conditions were employed in the reaction of iminoester 
4ab with the chiral complex generated from ligand (Sa)-1, but 
disappointing results were again achieved (Table 1, compare 
entries 17 and 18). It was also noticeable that tert-butyl iminoester 
4ac (R = tBu) were not appropriate as substrates for this particular 
transformation because the yields, conversions and 
enantioselectivities were extremely low. 
When the enantiomeric ligand (Ra,S,S)-3 was employed, both 
iminoesters (4aa, and 4ab) afforded at −20 ºC the corresponding 
enantiomer of 5aa and 5ab, respectively (Table 1, entries 14 and 
19). By contrast, complexes formed by phosphoramidites (Ra,R,R)-
3 or (Sa,S,S)-3 and AgClO4 demonstrated to be mismatched 
combinations because the reaction of 4ab and tert-butyl acrylate 
afforded, in each example, compound ent-5ab with a 28:72 er 
(Table 1, entries 20 and 21). Smaller amounts of a catalyst loading 
(3 mol-%) in the reaction at −20 ºC gave lower yield but similar 
enantioselectivity of 5ab (Table 1, entry 22). 
Other solvents, such as THF, dichloromethane, diethyl ether, 
acetonitrile, and methanol gave both lower conversions and er 
values. In all of the examples shown in Tables across the main text, 
the endo-adduct[20] was obtained as the major stereoisomer with a 
dr value higher than 98:2 (1H NMR). All of the er data were 
determined by chiral HPLC analysis, and the absolute 
configuration was assigned by comparison of the optical rotations 
between the newly generated products and the reported data for the 
same compounds.[11]  
<<Table 1>> 
The new 1:1 and 2:1 complexes of AgClO4 and 
phosphoramidite  (Sa,R,R)-3 were characterised by X-ray 
crystallographic diffraction of monocrystals.[11c] Whilst the 1:1 
(Sa,R,R)-3:AgClO4 complex formed cross-linked sheets, the 2:1 
mixture afforded well defined crystals. The formation of these 
polymeric assemblies are typical of silver(I) complexes, 
independently of the mono- or bidentate character of the 
corresponding ligand.[21] These complexes are soluble in toluene 
and could not be recovered from the reaction mixture as in the case 
of the complex formed by Binap and AgClO4.[11b,d] 
The ESI-MS experiments of the 1:1 and 2:1 (Sa,R,R)-3:AgClO4 
complexes revealed M++1 peaks at 646 and 1187, respectively. 
When an equimolar amounts of the 1,3-dipole precursor 4aa, 
triethylamine, and a 1:1 mixture of (Sa,R,R)-3:AgClO4 complex 
were put together, the ESI experiment revealed a very abundant 
species with m/z = 824, due to the formation of the chiral silver 
complex-dipole adduct I (Figure 2) and a tiny peak at 1000 as a 
result of the combination of two molecules of dipole to the chiral 
silver complex. This intermediate complex I was represented also 
for explaining the both high distereo- and enantioselection offered 
by the matched combination of the stereochemical elements of 
ligand (Sa,R,R)-3.   
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Figure 2. Suggested structure of intermediate complex I. 
Analogous 31P NMR (CDCl3, 10 mol-% aq. polyphosphoric 
acid as internal reference) experiments also revealed interesting 
aspects. Only a wide band centered at 126.9 ppm was observed 
when a 1:1 mixture of (Sa,R,R)-3:AgClO4 was formed in solution, 
which corresponded to its polymeric character detected by X-ray 
diffraction analysis. However, two separated bands were observed 
at 124.9 and 132.0 ppm in the case of a 2:1 mixture as a 
consequence of the partial disaggregation. The almost complete 
disaggregation of the polymeric sheets of the 1:1 complex was 
achieved with the addition of 1 equiv. of the 1,3-dipole generate 
from 4aa and triethylamine. The result was the transformation of 
the original 31P NMR band into two perfectly defined doublets at 
125.1 (JP-Ag(109) = 76 Hz) and 133.61 ppm (JP-Ag(107) = 73 Hz), 
which, seems to correspond to the phosphorous atom of the 
complex I. 
Due to perchlorates are classified as low order explosives the 
thermal stability of the 1:1 mixture of (Sa,R,R)-3:AgClO4 complex 
was studied. The thermogravimetric (TG) and differential thermal 
analysis (DTA) of this complex (Figure 3) revealed that the loss of 
water occurred from 50 to 150 ºC without any variation of the heat 
of the system. The exothermic decomposition of the complex 
started at 200 ºC approximately, continuing till 600 ºC with a 
noticeable heat liberation. 
  
Figure 3. TG and DTA plots of (Sa,R,R)-3:AgClO4 complex. 
Then, the general scope of the enantioselective 1,3-DC of 
azomethine ylides, generated from iminoesters, with electrophilic 
alkenes, catalyzed by a 5 mol-% of a 1:1 mixture of (Sa,R,R)-
3:AgClO4 complex in toluene and in the presence of a base, was 
studied. Firstly, glycine-derived iminoesters 4 were allowed to 
react with tert-butyl acrylate under the previously described 
conditions using triethylamine or DABCO (5 mol-%) at several 
temperatures (Scheme 2 and Table 2). The presence of an isopropyl 
ester in the molecule 4ab, rather than the methyl ester, was very 
important because the reaction performed at −20 ºC, independently 
of the used base, afforded endo-cycloadduct 5ab in good yield 
(81%) with a >99:1 er (Table 2, entries 1-4). The ortho-substituted 
aryl imines 4ba and 4ca gave satisfactory results by employing 
DABCO as base at −20 ºC. The er of both cycloadducts 5ba and 
5ca was very high after purification (>99:1) (Table 2, entries 5-8). 
In these last examples the presence of an isopropyl group was not 
so advantageous as before.  
For para-substituted aryl imines, the best results were 
achieved using Et3N as base at −20 ºC, and isopropyl rather than 
methyl esters of N-arylideneimino glycinates 4. The increment in 
the enantiomeric ratio was very small for the endo-cycloadducts 
5da, 5db and 5fa, 5fb (Table 2, entries 9-13 and 18-21, 
respectively), but was significant for the endo-5eb (99:1 er, Table 
2, entries 14-17). The 2-naphthyl derivative 4ga furnished better 
yields and enantioselections for the methyl esters than the 
analogous isopropyl esters (not shown in Table 2), using Et3N as 
base at −20 ºC. The corresponding endo-product 5ga was obtained 
in 84% yield and 96:4 er after flash chromatography (Table 2, 
entries 22-24). 
Ar N CO2R
4
tBuO2C
N
H
tBuO2C
Ar CO2R
endo-5
AgClO4 (5 mol-%)
(Sa,R,R)-3 (5 mol-%)
base (5 mol-%)
toluene, T [º C]
17 h  
Scheme 2 
<<Table 2>> 
 Different dipolarophiles were allowed to react with several 
iminoesters (Scheme 3 and Table 3). Glycine derived iminoesters 
reacted in very good yields with maleimides at higher temperatures 
(rt or 0 ºC) obtaining excellent enantioselectivities of the 
corresponding cycloadducts 9aa and 10aa (Table 3, entries 1 and 
2). Fumarates, chalcone and cyclopent-2-enone were very suitable 
dipolarophiles employing triethylamine as base at −20 ºC. The 
yields were in a 72-81% range and the enantioselections were very 
important, especially in the examples run with chalcone (>99:1 er) 
(Table 3, entries 3-8). 
 α-Substituted iminoesters derived from alanine, phenylalanine 
and leucine reacted with tert-butyl acrylate to give endo-
cycloadducts 16-19 in good purified yields and very high 
enantioselectivities (Table 3, entries 9-15). The best results were 
always achieved using Et3N as base at −20 ºC rather than 
employing DABCO (Table 3, entries 9-15). N-Methylmaleimide 
(NMM) furnished good yields of cycloadducts 20 and 21 and high 
enantiomeric ratios under the analogous reaction conditions, 
phenylalanine derivative 7aa being the less reactive system (Table 
3, entries 16-19). Chalcone and (E)-pent-3-enone also reacted with 
alanine dipole precursors 6aa and 6ga giving good yields of 
proline derivatives 22aa and 23ga in good yields, with 90:10 and 
84:16 er, respectively (Table 3, entries 20 and 21). In all of these 
examples the presence of isopropyl or tert-buyl esters produced 
lower enantioselections and very long reaction times. Many of 
these cycloadducts are known compounds and the comparison of 
their physical and spectroscopic data obtained and the reported data 
confirm the absolute configuration represented on each structure.  
TG 
DTA 
 4
Ar N CO2Me
R
dipolarophile
AgClO4 (5 mol-%)
(Sa,R,R)-3 (5 mol-%)
base (5 mol-%)
toluene, 17 h, T [ºC]
endo-cycloadduct
4, 6-8
+ 9-23
 
Scheme 3 
<<Table 3>> 
It has been demonstrated that enantiomerically pure proline 
derivative 19ha is the key precursor to a series of antiviral agents 
inhibitors of the hepatitis C virus (HCV) polymerase[15a][16a][ 22 ] 
such as prolinamide 26.[5a][23] The intermediate prolinamide 25 was 
synthesized in 88% yield (estimated by 1H NMR) from 
enantiomerically pure 19ha by a simple amidation reaction with 4-
(trifluoromethyl)benzoyl chloride in refluxing dichloromethane 
during 19 h. The crude product was submitted, in a second step, to 
a hydrolysis of the tert-butyl ester with trifluoroacetic acid 
followed by the methyl ester hydrolysis using an aqueous solution 
of KOH in methanol for 16 h. The resulting dicarboxylic acid 26 
was finally obtained in 81% yield from compound 25 (50% overall 
yield from iminoester 8ha) (Scheme 4). The purity of the antiviral 
agent was >98% and only 0.7 ppm of silver were present in this 
sample according to inductively coupled plasma mass spectrometry 
(ICP-MS) analysis. On the basis of this instrumental technique, 
purified samples of compound 19ha only contained around 4 ppm 
of silver. 
N
H
tBuO2C
CO2MeS
(2S,4S,5R)-19ha
91:9 er
4-CF3C6H4COCl
DCM, Et3N, 19h
reflux
N
tBuO2C
CO2MeS
(2S,4S,5R)-25
91:9 er
O
F3C
(88%)
1) TFA, DCM, 18 h
2) KOH, MeOH/H2O
    reflux, 20 h
N
HO2C
CO2HS
(2S,4S,5R)-26
93:7 er
O
F3C
(81%)
 
Scheme 4. 
With the aim of getting a better understanding of the origins of 
the observed stereocontrol we carried out different calculations 
(see below for technical details) on the interaction modes between 
t-butyl acrylate and the complex II formed by 1,3-dipole precursor 
4aa and (Sa)-Monophos 1. Since we have determined that non-
linear effects have not been observed in these reactions, only 
monomeric species were considered along the different reaction 
paths. Our results indicate that the formal [3+2] cycloaddition is 
actually a stepwise process[24] in which the first step consist of a 
Michael addition of II on t-butyl acrylate. This step determines the 
stereochemical outcome of the whole reaction. The possible 
cycloadducts 27 and the corresponding transition structures TS1 
that lead to them are depicted in Scheme 5. 
<Scheme 5> 
Calculations located and characterized the four possible 
transition structures and their main organic features are gathered in 
Figure 4. The less energetic saddle points are those that exhibit the 
t-butoxycarboxyl group in an endo relationship with respect to the 
phenyl group of 4aa. Both TS1-SRR and TS1-RSS lack the highly 
stabilizing bonding interaction between the t-butoxycarbonyl 
moiety and the metallic centre. As a consequence, these transition 
structures are ca. 10 kcal/mol less stable than their endo-analogues. 
The two possible endo-TS1 saddle points were much closer in 
energy (Figure 4). However, TS1-SSR was calculated to be 1.31 
kcal/mol lower in energy than TS1-RRS. It is observed that the 
dihedral angle formed by the two naphthyl groups is of ca. 57-58 
deg. In the case of TS1-SSR, this lead to the blockage of the Re-Si 
face of the dipole. Since there is a stronger steric congestion 
between one naphthyl group and the tert-butyl group of the 
dipolarophile in TS1-RRS (Figure 4). This results, in the 
preferential formation of the endo-(2S,4S,5R)-27, were in good 
agreement with the experimental results. 
<Figure 4> 
The reaction coordinate associated with the 1,3-DC between 
tert-butyl acrylate and complex II to form cycloadduct endo-
(2S,4S,5R)-27 is gathered in Figure 5. Reaction between the 
dipolarophile and complex II results in the formation of complex 
28. The computed reaction barrier to form zwiterionic intermediate 
29-SSR via TS1-SSR is ca. 13 kcal/mol. In this first step complex 
II and tert-butyl acrylate behave as a silver enolate and a Michael 
acceptor, respectively. Intermediate 29-SSR cyclises to endo-
(2S,4S,5R)-27 via an intramolecular Mannich-like reaction through 
TS2-SSR with a reaction barrier of ca. 3 kcal/mol. Therefore, the 
Michael addition reaction determines the stereoselectivity of the 
stepwise 1,3-DC and it is also the limiting step. 
It is interesting to note that endo-(2S,4S,5R)-27 is ca. 5 
kcal/mol less stable than 28 because of the strain induced by the 
coordination pattern around the metallic centre after the complete 
cyclisation. This ensures the catalyst recovery and the delivery of 
the endo-NH-cycloadduct 5aa. 
<Figure 5> 
The simulation of the geometry of intermediate complex II 
also revealed that a torsion dihedral angle (ca 23º) exists between 
the imaginary dipole-containing plane and the plane defined by the 
imine aromatic ring (Figure 6a, see also Figure 4). This detail, a 
priori insignificant, can seriously affect the reaction rate. It was 
experimentally observed that the optimised enantioselective 
reaction of iminoester 8ha (methyl 2-thienyliminoleucinate) and 
tert-butyl acrylate was completed in 48 h, but the analogous 
reaction attempted with the iminoester 8aa (methyl 
phenyliminoleucinate) did not react at all after 48 h. In fact, 2-
thienyliminoglycinate could not be used as starting material 
because it reacted with itself (forming the presumed imidazolidine 
according to 1H NMR) rather than with the added dipolarophile, 
unlike the methyl phenyliminoglycynate 4aa did. This different 
reactivity can be, presumably, originated by a better 
hyperconjugation of the enolate in the presence of the thienyl 
substituent due to the existence of a more planar conformation of 
the complexes III than in the complex IV. These hypotheses were 
supported by NOESY experiments performed on complexes III 
and IV, whose results are depicted in Figure 6b. The phenyl ring 
has to rotate in intermediate complex IV, such as it was observed 
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in complex II, in order to ensure the interaction of the aromatic 
π−electronic current with the silver cation.[25]  
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Figure 6. (a) Geometrical features of the complex II. Angles in deg. (b) nOe effects 
observed in intermediate complexes III and IV. 
Conclusions 
The novel equimolar monodentate phosphoramidite (Sa,R,R)-3-
silver perchlorate complex is a very efficient chiral catalyst for a 
wide range of 1,3-dipolar cycloaddition reactions between 
azomethine ylides and dipolarophiles. This type of monodentate 
complexes open new perspectives in this and other reactions 
because is capable to perform cycloadditions involving sterically 
hindered components, the fine-tuning being achieved by 
modification of the temperature, base and ester substituent. A 
direct application of this methodology is the direct synthesis of 
dicarboxylic acid 26, a very effective agent inhibitor of the HCV 
polymerase. It was isolated in 50% overall yield (4 steps) with a 
93:7 er. The overall cyclisation process occurred through a non-
concerted reaction, Michael-type addition being the determinant 
step of the stereochemical outcome of the cyclisation reaction.  
Experimental Section 
General. All reactions were carried out in the absence of light. Anhydrous 
solvents were freshly distilled under an argon atmosphere. Aldehydes were 
also distilled prior to use for the elaboration of the iminoesters. Melting 
points were determined with a Reichert Thermovar hot plate apparatus and 
are uncorrected. Only the structurally most important peaks of the IR 
spectra (recorded on a Nicolet 510 P-FT) are listed. 1H NMR (300 MHz) 
and 13C NMR (75 MHz) spectra were obtained on a Bruker AC-300 using 
CDCl3 as solvent and TMS as internal standard, unless otherwise stated. 
Optical rotations were measured on a Perkin Elmer 341 polarimeter. HPLC 
analyses were performed on a JASCO 2000-series equipped with a chiral 
column (detailed for each compound in the main text), using mixtures of n-
hexane/isopropyl alcohol as mobile phase, at 25 ºC. Thermal analysis 
studies were done in TG-DTA METTLER TOLEDO 
TGA/SDTA851e/SF/1100. Low-resolution electron impact (EI) mass 
spectra were obtained at 70eV on a Shimadzu QP-5000 and high-resolution 
mass spectra were obtained on a Finnigan VG Platform. HRMS (EI) were 
recorded on a Finnigan MAT 95S. Microanalyses were performed on a 
Perkin Elmer 2400 and a Carlo Erba EA1108. Analytical TLC was 
performed on Schleicher & Schuell F1400/LS silica gel plates and the spots 
were visualized under UV light (λ = 254 nm). For flash chromatography we 
employed Merck silica gel 60 (0.040-0.063 mm). 
 
Computational methods. All the calculations were obtained with the 
GAUSSIAN03 suite of programs.[ 26 ] Electron correlation was partially 
taken into account using the hybrid functional B3LYP[27] and the standard 
6-31G* basis set 28  for hydrogen, carbon, oxygen, phosphorous and 
nitrogen, and the Hay-Wadt small core effective potential (ECP)[ 29 ] 
including double-ξ valence basis set[ 30 ] for silver atoms (LanL2DZ 
keyword). Zero point vibrational energy (ZPVE) corrections were 
computed at the B3LYP/LanL2DZ&6-31G* level and were not scaled. All 
stationary points were characterized by harmonic analysis. Reactants 
intermediates and cycloadducts have positive definite Hessian matrices. 
Transition structures shown only one negative eigenvalue in their 
diagonalysed force constant matrices, and their associated eigenvectors 
were confirmed to correspond to the motion along the reaction coordinate 
under consideration (for more details, see supporting information). 
 
1,3-Dipolar cycloaddition of iminoesters and dipolarophiles. General 
procedure. A solution of the iminoester  (1 mmol) and dipolarophile (1 
mmol) in toluene (5 mL) was added to a suspension containing  the 
phosphoramidite (0.05 mmol) and AgClO4 (0.05 mmol, 10 mg) in toluene 
(5 mL). To the resulting suspension triethylamine (0.05 mmol, 7 μL) was 
added and the mixture stirred at the temperature indicated in the text and in 
the absence of the light for 16-48 h. The precipitate was filtered and the 
organic phase was directly evaporated and the residue was purified by 
recrystallization or by flash chromatography yielding pure endo-
cycloadducts (see Tables 2 and 3 for details). 
 
4-tert-Butyl 2-methyl (2S,4S,5R)-5-phenyl-2,4-pyrrolidinodicarboxylate 
(5aa):[11j] (254 mg, 80%). 
 
4-tert-Butyl 2-isopropyl (2S,4S,5R)-5-phenyl-2,4-pyrrolidinodicarboxylate 
(5ab): Sticky oil (276 mg, 83%); [α]D20 = +20.1º  (c = 0.9, CHCl3, 99% ee 
by HPLC); Rf: 0.46 (n-hexane/ethyl acetate: 3/2); IR (KBr) ν: 1727, 1705, 
2977 cm-1; 1H NMR δH: 1.03 [s, 9H, CO2C(CH3)3], 1.30 [d, J = 6.3 Hz, 3H, 
CO2CH(CH3)2], 2.26 (m, 1H, CH2), 2.44 (m, 1H, CH2), 2.69 (broad s, 1H, 
NH), 3.26 (m, 1H, CHCO2tBu), 3.89 (dd, J = 8.4, 8.4 Hz, 1H, CHCO2iPr), 
4.48 (d, J = 7.9 Hz, 1H, CHPh), 5.15 [sept, J = 6.3 Hz, 1H, CO2CH(CH3)2], 
7.21-7.38 (m, 5H, ArH); 13C NMR δC: 21.8 [CO2CH(CH3)2], 27.4 
[CO2C(CH3)3], 34.3 (CH2), 50.3 (CHCO2tBu), 60.2 (CHCO2iPr), 65.6 
[CO2CH(CH3)2], 68.6 (Ph-CH), 80.5 [CO2C(CH3)3], 127.2, 127.3, 128.1 
(ArCH), 139.5 (ArC), 171.8, 172.8 (CO2iPr, CO2tBu); MS (EI)  m/z (%): 
333 (M+, 0.78%), 246 (47), 205 (12), 191 (13), 190 (100), 172 (13), 163 
(11), 145 (12), 144 (31), 117 (22); HRMS calcd. for C19H27NO4: 333.1940, 
found: 333.1929; HPLC (column AS, 1 mL/min, n-hexane/i-PrOH: 99:1, λ 
220 nm), tRmaj = 15.3 min, tRmin = 58.5 min. 
 
4-tert-Butyl 2-methyl (2S,4S,5R)-5-(2-methylphenyl)-2,4-
pyrrolidinodicarboxylate (5ba):[11j] (276 mg, 83%). 
 
4-tert-Butyl 2-methyl (2S,4S,5R)-5-(2-chlorophenyl)-2,4-
pyrrolidinodicarboxylate (5ca):[11j] (283 mg, 80%). 
 
4-tert-Butyl 2-methyl (2S,4S,5R)-5-(4-methylphenyl)-2,4-
pyrrolidinodicarboxylate (5da):[11j] (260 mg, 78%). 
 
4-tert-Butyl 2-isopropyl (2S,4S,5R)-5-(4-methylphenyl)-2,4-
pyrrolidinodicarboxylate (5db): Sticky oil (278 mg, 80%); [α]D20 = +44.1º  
(c = 1, CHCl3, 99% ee by HPLC); Rf: 0.43 (n-hexane/ethyl acetate: 3/2); IR 
(liq.) ν: 1727, 3018 cm-1; 1H NMR δH: 1.07 [s, 9H, CO2C(CH3)3], 1.30 [d, J 
= 6.2 Hz, 3H, CO2CH(CH3)2], 2.32 (s, 3H, PhCH3), 2.50 (m, 1H, CH2), 2.44 
(m, 1H, CH2), 3.31 (dd, J = 13.9, 7.7 Hz, 1H, CHCO2tBu), 4.07 (dd, J = 
8.4, 8.2 Hz, 1H, CHCO2iPr), 4.59 (d, J = 7.8 Hz, 1H, CHPh), 5.15 [m, 1H, 
CO2CH(CH3)2], 7.13 (d, J = 8.0 Hz, 2H, ArH), 7.23 (d, J = 8.1 Hz, 2H, 
ArH); 13C NMR δC: 21.0 (ArCH3), 21.7 [CO2CH(CH3)2], 27.5 
[CO2C(CH3)3], 33.6 (CH2), 51.0 (CHCO2tBu), 59.7 (CHCO2iPr), 65.2 
[CO2CH(CH3)2], 69.6 (ArCH), 81.2 [CO2C(CH3)3], 127.0, 129.1 (ArCH), 
137.5, 137.6 (ArC), 171.4, 171.6 (CO2iPr, CO2tBu); MS (EI)  m/z (%): 347 
(M+, 1.35%), 290 (16), 274 (12), 260 (46), 219 (25), 205 (14), 204 (100), 
186 (25), 177 (12), 160 (13), 159 (21), 158 (42), 143 (17), 131 (46), 57 
(12), 56 (14); HRMS calcd. for C20H29NO4: 347.2097, found: 347.2102; 
HPLC (column Chiralpak AS, 1 mL/min, n-hexane/i-PrOH 95:5, λ 220 
nm), tRmaj = 6.8 min, tRmin = 18.6 min. 
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4-tert-Butyl 2-methyl (2S,4S,5R)-5-(4-methoxyphenyl)-2,4-
pyrrolidinodicarboxylate (5ea):[11j] (275 mg, 79%). 
 
4-tert-Butyl 2-isopropyl (2S,4S,5R)-5-(4-methoxyphenyl)-2,4-
pyrrolidinodicarboxylate (5eb): Sticky oil (290 mg, 80%); [α]D20 = +26.6º  
(c = 0.9, CHCl3, 98% ee by HPLC); Rf: 0.37 (n-hexane/ethyl acetate: 3/2); 
IR (liq.) ν: 1730, 1727, 2978 cm-1; 1H NMR δH: 1.07 [s, 9H, CO2C(CH3)3], 
1.30 [d, J = 6.3 Hz, 6H, CO2CH(CH3)2], 2.25 (m, 1H, CH2), 2.41 (m, 1H, 
CH2), 3.24 (dd, J = 14.7, 7.7 Hz, 1H, CHCO2tBu), 3.79 (s, 3H, OCH3), 3.86 
(m, 1H, CHCO2iPr), 4.43 (d, J = 7.9 Hz, 1H, CHAr), 5.14 [sept, J = 6.3, 
1H, CO2CH(CH3)2], 6.85 (d, J = 8.8 Hz, 2H, ArH), 7.28 (d, J = 8.7 Hz, 2H, 
ArH); 13C NMR δC: 21.8 [CO2CH(CH3)2], 27.5 [CO2C(CH3)3], 34.2 (CH2), 
50.4 (CHCO2tBu), 55.3 (OCH3), 60.1 (CHCO2iPr), 65.0 [CO2CH(CH3)2], 
68.7 (PhCH), 80.5 [CO2C(CH3)3], 113.5, 128.3 (ArCH), 131.8, 158.8 
(ArC), 171.9, 172.9 (CO2iPr, CO2tBu); MS (EI)  m/z (%): 363 (M+, 2.9%), 
306 (41), 290 (23), 276 (43), 235 (61), 221 (10), 220 (70), 202 (32), 193 
(14), 176 (27), 175 (39), 174 (30), 159 (19), 148 (18), 147 (100), 135 (11), 
132 (16), 57 (14), 56 (41), 55 (18); HRMS calcd. for C20H29NO5: 363.2046, 
found: 363.2029; HPLC (column AS, 1 mL/min, n-hexane/i-PrOH: 95:5, λ 
220 nm), tRmaj = 9.5 min, tRmin = 24.9 min. 
 
4-tert-Butyl 2-methyl (2S,4S,5R)-5-(4-chlorophenyl)-2,4-
pyrrolidinodicarboxylate (5fa).[11j] (269 mg, 76%). 
 
4-tert-Butyl 2-isopropyl (2S,4S,5R)-5-(4-chlorophenyl)-2,4-
pyrrolidinodicarboxylate (5fb): Colourless prisms (283 mg, 77%); mp: 88-
90 ºC (CH2Cl2/hexane); [α]D20 = +23.6º  (c = 0.8, CHCl3, 94% ee by 
HPLC); Rf: 0.46 (n-hexane/ethyl acetate: 3/2); IR (liq.) ν: 1737, 1709, 2978 
cm-1; 1H NMR δH: 1.06 [s, 9H, CO2C(CH3)3], 1.29 [d, J = 6.3 Hz, 3H, 
CO2CH(CH3)2], 1.30 [d, J = 6.3 Hz, 3H, CO2CH(CH3)2], 2.26 (m, 1H, 
CH2), 2.44 (m, 1H, CH2), 3.26 (dd, J = 14.7, 7.8 Hz, 1H, CHCO2tBu), 3.89 
(dd, J = 8.4, 8.4 Hz, 1H, CHCO2iPr), 4.43 (d, J = 7.8 Hz, 1H, CHPh), 5.15 
[sept, J = 6.2, 1H, CO2CH(CH3)2], 7.25-7.31 (m, 4H, ArH); 13C NMR δC: 
21.8 [CO2CH(CH3)2], 27.5 [CO2C(CH3)3], 33.9 (CH2), 50.1 (CHCO2tBu), 
60.0 (CHCO2iPr), 64.8 [CO2CH(CH3)2], 68.8 (ArCH), 80.8 [CO2C(CH3)3], 
128.2, 128.6, 133.1, 138.3 (ArC), 171.5, 172.9 (CO2iPr, CO2tBu); MS (EI)  
m/z (%): 367 (M+, 0.66%), 282 (14), 280 (40), 239 (10), 226 (33), 225 (13), 
224 (100), 206 (15), 197 (12), 180 (12), 179 (13), 178 (18), 151 (19), 57 
(11); HRMS calcd. for C19H26ClNO4: 367.1550, found: 367.1547; HPLC 
(column AS, 1 mL/min, n-hexane/i-PrOH: 95:5, λ 220 nm), tRmaj = 6.7 min, 
tRmin = 16.5 min. 
 
4-tert-Butyl 2-methyl (2S,4S,5R)-5-(2-naphthyl)-2,4-
pyrrolidinodicarboxylate (5ga):[11j] (299 mg, 78%). 
 
Methyl (1S,3R,3aS,6aR)-5-methyl-3-phenyl-4,6-
dioxooctahydropyrrolo[3,4-c]pyrrole-1-carboxylate (9aa):[11b] (230 mg, 
80%). 
 
Methyl (1S,3R3aS,6aR)-5-ethyl-3-phenyl-4,6-dioxooctahydropyrrolo[3,4-
c]pyrrole-1-carboxylate (10aa)[11b]: (236 mg, 78%). 
 
3,4-Diisopropyl 2-methyl (2S,3S,4S,5R)-5-phenyl-2,3,4-
pyrrolidinotricarboxylate (11aa): Sticky oil (305 mg, 81%); [α]D20 =  32.1º 
(c = 0.5, CHCl3, 82% ee by HPLC); Rf: 0.37 (n-hexane/ethyl acetate: 3/2); 
IR (liq.) ν: 1741, 1731, 2982 cm-1; 1H NMR δH: 0.65 [d, J = 6.2 Hz, 3H, 
CH(CH3)2], 0.94 [d, J = 6.2 Hz, 3H, CH(CH3)2], 1.27 [d, J = 6.2 Hz, 3H, 
CH(CH3)2], 1.28 [d, J = 6.2 Hz, 3H, CH(CH3)2], 2.86 (broad s, 1H, NH), 
3.55 (m, 2H, 2×CHCO2iPr), 3.83 (s, 3H, CO2CH3), 4.14 (d, J = 7.3 Hz, 1H, 
CHCO2Me), 4.56 [sept, J = 6.2 Hz, 1H, CH(CH3)2], 4.65 (d, J = 7.3 Hz, 
1H, CHPh), 5.08 [sept, J = 6.2 Hz, 1H, CH(CH3)2], 7.22-7.34 (m, 5H, 
ArH); 13C NMR δC: 20.8, 21.4, 21.6 [CH(CH3)2], 51.4, 52.4 (CHCO2iPr), 
53.8 (CO2CH3), 63.4 [CHCO2Me], 65.2 (PhCH), 68.2, 68.8 [CH(CH3)2], 
127.0, 127.7, 128.2, 138.4 (ArC), 170.5, 171.5, 171.6 (CO2Me, CO2iPr); 
MS (EI)  m/z (%): 377 (M+, 14%), 318 (33), 317 (23), 316 (23), 290 (20), 
276 (17), 274 (12), 258 (38), 248 (15), 230 (43), 228 (17), 216 (10), 205 
(25), 202 (50), 188 (47), 187 (23), 177 (67), 170 (34), 149 (12), 146 (29), 
145 (46), 144 (100), 143 (29), 119 (22), 118 (19), 117 (96), 116 (14), 115 
(28), 106 (11), 104 (10), 91 (12), 90 (10); HRMS calcd. for C20H27NO6: 
377.1838, found: 377.1843; HPLC (column OD-H, 1 mL/min, n-hexane/i-
PrOH: 80:20, λ 220 nm), tRmaj = 6.6 min, tRmin = 13.5 min. 
 
3,4-Diisobutyl 2-methyl (2S,3S,4S,5R)-5-phenyl-2,3,4-
pyrrolidinotricarboxylate (12aa): Sticky oil (320 mg, 79%); [α]D20 =  47.1º 
(c = 0.5, CHCl3, 82% ee by HPLC); Rf: 0.56 (n-hexane/ethyl acetate: 1/5); 
IR (liq.) ν: 1737 1730, 2958 cm-1; 1H NMR δH: 0.66 [d, J = 6.7 Hz, 3H, 
CH(CH3)2], 0.68 [d, J = 6.6 Hz, 3H, CH(CH3)2], 0.95 [d, J = 6.7 Hz, 6H, 
CH(CH3)2], 1.51 [d, J = 6.7 Hz, 1H, CH(CH3)2], 1.63 (broad s, 1H, NH), 
1.97 [d, J = 6.7 Hz, 1H, CH(CH3)2], 3.25 [dd, J = 10.5, 6.6 Hz, 1H, 
CH2CH(CH3)2], 3.50 [dd, J = 10.6, 6.6 Hz, 1H, CH2CH(CH3)2], 3.63 (m, 
2H, 2×CHCO2iBu), 3.83 (s, 3H, CO2CH3), 3.96 [m, 2H, CH2CH(CH3)2], 
4.19 (d, J = 7.3 Hz, 1H, CHCO2Me), 4.66 (d, J = 7.5 Hz, 1H, CHPh), 7.25-
7.32 (m, 5H, ArH); 13C NMR δC: 18.8, 18.9, 19.0 [CH(CH3)2], 27.2, 27.7 
[CH(CH3)2], 51.3 (CHCO2iBu), 52.5 (CO2CH3), 54.0 (CHCO2iBu), 63.4 
[CHCO2Me], 65.5 (PhCH), 71.1, 71.5 (2xCH2), 126.9, 127.8, 128.3, 138.1 
(ArC), 171.4, 172.1, 172.2 (CO2Me, 2xCO2iBu); MS (EI)  m/z (%): 405 
(M+, 11%), 346 (11), 345 (22), 332 (20), 304 (20), 272 (36), 245 (11), 244 
(54), 219 (11), 202 (38), 188 (38), 178 (11), 177 (90), 170 (26), 164 (46), 
155 (12),149 (14), 146 (54), 145 (46), 144 (82), 143 (24), 119 (12), 118 
(19), 117 (100), 116 (13), 115 (21), 106 (11), 105 (11), 90 (11), 57 (46), 56 
(21), 55 (12); HRMS calcd. for C22H31NO6: 405.2151, found: 405.2151; 
HPLC (column OD-H, 1 mL/min, n-hexane/i-PrOH: 80:20, λ 220 nm), tRmaj 
= 8.5 min, tRmin = 16.7 min. 
 
2-Methyl (2S,3R,4S,5R)-4-benzoyl-3,5-diphenyl-2-pyrrolidinocarboxylate 
(13aa): Colourless needles (262 mg, 80%); mp: 152 ºC (hexane/ethyl 
acetate);  [α]D20 = −20º (c = 1 , CH2Cl2, 99% ee by HPLC); IR (KBr) ν: 
1673, 1741, 3435 cm-1; 1H NMR δΗ: 2.65 (s, 1H, NH), 3.74 (s, 3H, 
CO2Me), 4.21-4.09 (m, 2H, CHCOPh and CHCO2Me), 4.52 (t, J = 7.5 Hz, 
1H, CHPh), 5.00 (d, J = 8.6 Hz, 1H, CHAr ), 7.13-7.04 (m, 5H, ArH), 7.26-
7.21 (m, 3H, ArH), 7.41-7.31 (m, 5H, ArH), 7.54-7.51 (m, 2H, ArH) ppm. 
13C  RMN δC: 52.30 (CH3CO2), 52.65 (CHPh), 60.56 (CHCOPh), 66.62 
(CHCO2Me), 67.63 (PhCHNH), 127.11, 1.27.34, 127.72, 128.01, 128.10, 
128.18, 128.76, 132.75, 137.35, 138.90, 140.68 (ArC), 173.30 and 198.61 
(2xCO) ppm; HRMS (EI): (M-C2H3O2)+ found 327.1622 C23H21NO 
requires 327.1623; HPLC (column OD-H 90-10-1, λ = 220 nm) tRmaj = 18.4 
min, tRmin = 33.2 min. MS (EI) m/z 326 (M+, 12%). 
 
2-Methyl (2S,3R,4S,5R)-4-benzoyl-5-(2-methylphenyl)-3-phenyl-2-
pyrrolidinocarboxylate (14ba): Colourless prisms (141, 70%), mp: 128 ºC; 
[α]D20 = −9 (c = 1.15 , CH2Cl2, 99% ee by HPLC ); IR (KBr) ν: 1672, 1746, 
3373 cm-1; 1H NMR δΗ: 2.14 (s, 3H, CH3Ph), 3.77 (s, 3H, CO2CH3), 4.12-
410 (m, 2H, CHCOPh and CHCO2Me ), 4.52-4.43 (m, 1H, CHPh ), 5.11 (d, 
J = 8.3 Hz, 1H, CHAr), 6.75 (d, J = 7.7 Hz, 1H), 6.92 (t, J = 6.4 Hz, 1H, 
ArH), 7.17-7.05 (m, 3H, ArH), 7.41-7.24 (m, 9H, ArH) ppm.13C RMN δc : 
19.9 (CH3Ph), 52.7 (CH3CO2), 54.4 (CHPh), 59.7 (CHCO2Me), 63.3 
(CHCOPh), 68.5 (CHAr), 126.5, 126.6, 127.5, 127.7, 127.9, 127.9, 128.3, 
129.3, 130.3, 132.8, 135.2, 136.2, 138.1, 142.1 (ArC), 173.22 (CO2Me), 
200.93 (COPh) ppm; MS (EI) m/z 340  (M+, 15%); HRMS (EI): (M-
C2H3O2)+ found 340.1685 C24H22NO requires 341.1780; HPLC (column 
Chiralpak OD-H 90-10-1, λ = 220 nm) tRmaj = 19.7,  tRmin = 24.8.  
 
2-Methyl (2S,3R,4S,5R)-4-benzoyl-5-(4-methylphenyl)-3-phenyl-2-
pyrrolidinocarboxylate (14da): Colourles prisms (256 mg, 75%), mp: 154 
ºC, [α]D20 = −25 (c = 1.06 , CH2Cl2, 90%  ee by HPLC); IR (KBr) ν: 1675, 
1741, 3374 cm-1; 1H NMR δΗ: 2.17 (s, 3H, CH3Ph), 3.73 (s, 3H, CO2Me), 
4.18-4.07 (m, 2H, CHCOPh and CHCO2Me), 4.50 (t, J = 7.8 Hz, 1H, 
CHPh), 4.97 (d, J = 8.6 Hz, 1H, CHAr), 6.9 (d, J = 8.0 Hz, 2H, ArH), 6.99 
(d, J = 8.1 Hz, 2H, ArH), 7.39-7.42 (m, 9H, ArH), 7.55 (d, J = 6.4 Hz, 2H, 
ArH) ppm; 13C  RMN δc: 20.9 (CH3Ph), 52.2 (CO2CH3), 52.6 (CHPh), 60.6 
(CHCO2Me), 66.4 (CHCOPh), 67.6 (CHAr), 127.2, 128.0, 128.7, 128.7, 
132.7, 136.0, 137.2, 137.4, 140.7 (ArC), 173.4 (CO2Me), 198.6 (COPh) 
ppm; MS (EI) m/z 340 (M+, 45%); HRMS (EI): (M-C2H3O2)+ found 
340.1705 C24H22NO requires 341.1780. HPLC (column Chiralpak ODH 90-
10-1 λ = 220 nm) tRmaj = 19.7,  tRmin = 24.8. 
  
Methyl (1S,3R,3aS,6aR)-octahydro-3-(naphthalen-2-yl)-4-
oxocyclopenta[c]pyrrole-1-carboxylate (15ga):[12b] (222 mg, 72%) 
 
4-tert-Butyl 2-methyl (2S,4S,5R)-2-methyl-5-phenyl-2,4-
pyrrolidinodicarboxylate (16aa):[11j] (238 mg, 78%) 
 
4-tert-Butyl 2-methyl (2S,4S,5R)-2-benzyl-5-phenyl-2,4-
pyrrolidinodicarboxylate (17aa):[11j] (293, 77%). 
  
4-tert-Butyl 2-methyl (2S,4S,5R)-2-methyl-5-(2-thienyl)-2,4-
pyrrolidinodicarboxylate (18ha): Sticky oil (257 mg, 79%); [α]D20 = +46.3º  
(c = 1, CHCl3, 92% ee by HPLC); Rf: 0.30 (n-hexane/ethyl acetate: 3/2); IR 
(liq.) ν: 1728, 1725, 2977 cm-1; 1H NMR δH: 1.15 [s, 9H, CO2C(CH3)3], 
1.46 (s, 1H, CCH3), 2.07 (dd, J = 13.7, 7.7 Hz, 1H, CH2), 2.70 (dd, J = 
13.7, 7.7 Hz, 1H, CH2), 3.35 (dd, J = 15.2, 7.7 Hz, 1H, CHCO2tBu), 3.79 
(s, 3H, CO2CH3), 4.81 (d, J = 7.5 Hz, 1H, CHAr), 6.91-6.95 (m, 2H, ArH), 
7.17 (dd, J = 4.9, 0.9 Hz, 1H, ArH); 13C NMR δC: 27.6 (CCH3), 27.8 
(CCH3), 39.4 (CH2), 50.6 (CHCO2tBu), 52.5 [CO2C(CH3)3], 60.3 (ArCH), 
80.8 [CO2C(CH3)3], 124.1, 124.8, 126.5, 143.5 (ArC), 171.0, 176.3 
(CO2Me, CO2tBu); MS (EI)  m/z (%): 325 (M+, 3.4%), 268 (22), 267 (10), 
266 (65), 252 (26), 211 (12), 210 (100), 197 (56), 166 (15), 165 (15), 164 
(18), 137 (67), 96 (11), 57 (18), 53 (10); HRMS calcd. for C16H23NO4S: 
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325.1348, found: 325.1347; HPLC (column OD-H, 1 mL/min, n-hexane/i-
PrOH: 99:1, λ 220 nm), tRmaj = 13.4 min, tRmin = 14.8 min. 
 
4-tert-Butyl 2-methyl (2S,4S,5R)-2-isobutyl-5-(2-thienyl)-2,4-
pyrrolidinodicarboxylate (19ha): Viscous oil (257 mg, 70%); [α]D20 
= +38.6º  (c = 1, CHCl3, 84% ee by HPLC); Rf: 0.49 (n-hexane/ethyl 
acetate: 3/2); IR (liq.) ν: 1735, 1728, 2952 cm-1; 1H NMR δH: 0.82 [d, J = 
6.1 Hz, 3H, CH(CH3)2], 0.93 [d, J = 6.4 Hz, 3H, CH(CH3)2], 1.14 [s, 9H, 
CO2C(CH3)3], 1.58 [m, 1H, CH2CH(CH3)2], 1.75 [m, 2H, CH2CH(CH3)2], 
2.06 (dd, J = 13.6, 7.6 Hz, 1H, CCH2), 2.61 (dd, J = 13.7, 8.0 Hz, 1H, 
CCH2), 3.05 (broad s, 1H, NH), 3.29 (dd, J = 15.4, 7.8, 7.6 Hz, 1H, 
CHCO2tBu), 3.77 (s, 3H, CO2CH3), 4.76 (d, J = 7.5 Hz, 1H, CHAr), 6.90-
6.94 (m, 2H, ArH), 7.16 (dd, J = 4.8, 1.4 Hz, 1H, ArH); 13C NMR δC: 22.7 
[CH(CH3)2], 24.3 [CH(CH3)2], 25.0 [CH(CH3)2], 27.6 [CO2C(CH3)3], 39.9 
(CH2CHCO2tBu), 49.0 [CH2CH(CH3)2], 50.3 (CHCO2tBu), 52.2 (CO2CH3), 
60.3 (ArCH), 68.1 (CCO2Me), 80.7 [CO2C(CH3)3], 124.1, 124.9, 126.4, 
143.9 (ArC), 171.1, 176.4 (CO2Me, CO2tBu); MS (EI) m/z (%): 367 (M+, 
0.9%), 310 (14), 309 (13), 308 (65), 254 (18), 253 (16), 252 (100), 208 
(11), 196 (41), 179 (14), 57 (12); HRMS calcd. for C19H29NO4S: 367.1817, 
found: 367.1821; HPLC (column AD, 1 mL/min, n-hexane/i-PrOH: 99:1, λ 
220 nm), tRmaj = 11.1 min, tRmin = 13.7 min. 
 
Methyl (1S,3R3aS,6aR)-1,5-dimethyl-3-phenyl-4,6-
dioxooctahydropyrrolo[3,4-c]pyrrole-1-carboxylate (20aa):[11b] (242 mg, 
80%). 
 
Methyl (1S,3R3aS,6aR)-1-benzyl-5-methyl-4,6-dioxo-3-phenyl-
octahydropyrrolo[3,4-c]pyrrole-1-carboxylate (21aa):[11b] (302 mg, 80%). 
 
Methyl (2S,3R,4S,5R)-4-benzoyl-2-methyl-3,5-diphenyl-2-
pyrrolidinocarboxylate (22aa):[12b,31] (324%, 81%). 
 
Methyl (2S,3R,4S,5R)-4-acetyl-2,3-dimethyl-5-(2-naphthyl)-2-
pyrrolidinocarboxylate (23ga): Pale yellow oil (189 mg, 71%); [α]D20 = 20 
(c = 1.02, CH2Cl2, 65%  ee by HPLC); IR (NaCl) ν: 1689, 1722, 2958, 3312 
cm-1. 1H NMR δΗ: 1.19 (d, J = 6.2 Hz, 3H, CH3CH), 1.38 (s, 3H, CH3CN), 
1.61 (s, 3H, CH3CO), 2.99-3.04 (m, 1H, CHCH3), 3.29 (t, J = 10.3 Hz, 1H, 
CHCO), 3.82 (s, 3H, OCH3), 4.90 (d, J = 9.5 Hz, 1H CHN), 7.37-7.34 (m, 
2H, ArH), 7.48-7.43 (m, 3H, ArH) ppm. 13C  NMR δc: 19.77 (CH3CH), 
24.99 (CH3CCO), 30.60 (CHCH3), 42.58 (CHCO), 52.17 (CH3O), 62.23 
(CHCO), 64.47 (CHN), 125.05, 125.88, 126.38, 127.31 127.60 128.18, 
132.72, 137.67 (ArC), 175.57 (CO2), 206.59 (COCH3) ppm; MS(EI) m/z 
266 (M+); HRMS (EI): (M-C2H3O2)+ found 266.1552, C18H20NO requires 
266.1555; HPLC (column Chiralpak ODH 90-10-1, λ = 220 nm) tRmaj =10.5 
min,  tRmin = 12.2 min.   
 
Synthesis of antiviral compound (2S,4S,5R)-26. Compound (2S,4S,5R)-
8ha (1.2 mmol, 441 mg) was dissolved in dichlorometane (25 mL) and 
triethylamine (1.2 mmol, 166 μL) and 4-(trifluoromethyl)benzoyl chloride 
(1.2 mmol, 182 μL) were  slowly added at 0 ºC. The resulting mixture was 
refluxed overnight and the solvent was removed under vacuo (15 Torr). 
Crude compound (2S,4S,5R)-25, was allowed to react with trifluoroacetic 
acid/dichloromethane mixture (9.6 mL/18 mL). The resulting mixture was 
stirred at room temperature overnight and the solvent evaporated under 
vacuo. The residue was dissolved in a 1M solution of KOH in a 4/1 
MeOH/H2O (50 mL). This reaction was refluxed for 16 h. Methanol was 
evaporated and aqueous HCl (0.5 M, 20 mL) and ethyl acetate were added 
(2x20 mL). The combined organic phases were dried (MgSO4) and 
evaporated, yielding the crude compound (2S,4S,5R)-26, which was 
recrystallised from a mixture containing acetone/chloroform. 
 
(2S,4S,5R)-2-Isobutyl-5-(2-thienyl)-1-[4-(trifluoromethyl)benzoyl]-2,4-
pyrrolidinodicarboxílic acid  [(2S,4S,5R)-(+)-26]:[5a] (395 mg, 71% from 
19ha) 
  
Supporting Information (see footnote on the first page of this article). 
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Table 1. Optimization of the 1,3-DC of iminoesters 4 (1 equiv) and tert-butyl acrylate (1 equiv.) in toluene catalyzed by a 5 mol-% of both chiral ligand and 
AgI salt using 5 mol-% of base. 
Entry R Iminoester AgX Ligand Base T [ºC] t [h] Cycloadduct  Conv. [%] er[a] 
1 Me 4aa AgClO4 (Sa)-1 Et3N 20 8 5aa 98 76:24 
2 Me 4aa AgClO4 (Sa,R)-2 Et3N 20 8 5aa 98 69:31 
3 Me 4aa AgClO4 (Sa,R,R)-3 Et3N 20 8 5aa 98 85:15 
4 Me 4aa AgClO4[b] (Sa,R,R)-3 Et3N 20 8 5aa 95 74:26 
5 Me 4aa AgOAc (Sa,R,R)-3 Et3N 20 8 5aa 98 80:20 
6 Me 4aa AgOTf (Sa,R,R)-3 Et3N 20 8 5aa 98 84:16 
7 Me 4aa AgF (Sa,R,R)-3 Et3N 20 8 5aa 90 76:24 
8 Me 4aa AgBF4 (Sa,R,R)-3 Et3N 20 8 5aa 95 60:40 
9 Me 4aa AgClO4 (Sa,R,R)-3 Et3N 0 16 5aa 96 87:17 
10 Me 4aa AgClO4 (Sa,R,R)-3 Et3N −20 16 5aa 98 90:10 
11 Me 4aa AgClO4 (Sa)-1 Et3N −20 17 5aa 97 79:21 
12 Me 4aa AgClO4 (Sa,R,R)-3 DIPEA[c] −20 16 5aa 97 89:11 
13 Me 4aa AgClO4 (Sa,R,R)-3 DABCO −20 17 5aa 96 94:6 
14 Me 4aa AgClO4 (Ra,S,S)-3 DABCO −20 17 ent-5aa >98 6:94 
15 iPr 4ab AgClO4 (Sa,R,R)-3 Et3N 0 16 5ab >98 93:7 
16 iPr 4ab AgClO4 (Sa,R,R)-3 Et3N −20 16 5ab >98 >99:1 
17 iPr 4ab AgClO4 (Sa,R,R)-3 DABCO −20 16 5ab 97 >99:1 
18 iPr 4ab AgClO4 (Sa)-1 Et3N −20 17 5ab 94 53:47 
19 iPr 4ab AgClO4 (Ra,S,S)-3 Et3N −20 16 ent-5ab 97 <1:99 
20 iPr 4ab AgClO4 (Sa,R,R)-3 Et3N −20 16 ent-5ab 95 28:72 
21 iPr 4ab AgClO4 (Sa,S,S)-3 Et3N −20 16 ent-5ab  95 28:72 
22 iPr 4ab AgClO4[e] (Sa,R,R)-3 Et3N −20 16 5ab 76 98:2 
[a] Determined by chiral HPLC analysis (Daicel, Chiralpak AS) of the crude product. More than 98:2 endo:exo ratio by 1H NMR spectroscopy. [b] Reaction 
performed with two equivalents of the ligand 3 and 1 equiv. of silver perchlorate. [c] DIPEA = Diisopropylethylamine. [d] DABCO = 1,4-
Diazabicyclo[2.2.2]octane. [e] 3 Mol-% amount of the catalyst was employed. 
Table 2. 1,3-DC of glycine derived iminoesters 4 and tert-butyl acrylate catalyzed by 5 mol-% of (Sa,R,R)-3:AgClO4 complex.  
Entry Ar R 4 Base T [ºC] Cycloadduct 
No 
Yield [%][a] erendo[b] 
1 Ph Me 4aa Et3N −20 5aa 80 90:10 (90:10) 
2 Ph Me 4aa DABCO −20 5aa 80 94:6 (94:6) 
 9
3 Ph iPr 4ab Et3N −20 5ab 83 >99:1 (>91:1) 
4 Ph iPr 4ab DABCO −20 5ab 81 >99:1 (>91:1) 
5 2-Me-C6H4 Me 4ba DABCO 0 5ba 78 95:5 (95:5) 
6 2-Me-C6H4 Me 4ba DABCO −20 5ba 83 99:1 (>99:1) 
7 2-Cl-C6H4 Me 4ca DABCO 0 5ca 79 94:6 (95:5) 
8 2-Cl-C6H4 Me 4ca DABCO −20 5ca 80 98:2 (>99:1) 
9 4-Me-C6H4 Me 4da Et3N −20 5da 78 90:10 (90:10) 
10 4-Me-C6H4 Me 4da DABCO 0 5da 77 90:10 (91:9) 
11 4-Me-C6H4 Me 4da DABCO −20 5da 77 91:9 (92:8) 
12 4-Me-C6H4 iPr 4db Et3N −20 5db 80 95:5 (96:4) 
13 4-Me-C6H4 iPr 4db DABCO −20 5db 78 94:6 (95:5) 
14 4-MeO-C6H4 Me 4ea DABCO 0 5ea 77 94:6 (94:6) 
15 4-MeO-C6H4 Me 4ea DABCO −20 5ea 79 95:5 (96:4) 
16 4-MeO-C6H4 iPr 4eb Et3N −20 5eb 80 99:1 (99:1) 
17 4-MeO-C6H4 iPr 4eb DABCO −20 5eb 76 94:6 (95:5) 
18 4-Cl-C6H4 Me 4fa DABCO 0 5fa 77 92:8 (93:7) 
19 4-Cl-C6H4 Me 4fa DABCO −20 5fa 76 94:6 (95:5) 
20 4-Cl-C6H4 iPr 4fb Et3N −20 5fb 77 95:5 (97:3) 
21 4-Cl-C6H4 iPr 4fb DABCO 0 5fb 77 92:8 (94:6) 
22 2-Naphthyl Me 4ga Et3N −20 5ga 84 95:5 (96:4) 
23 2-Naphthyl Me 4ga DABCO 0 5ga 78 90:10 (90:10) 
24 2-Naphthyl Me 4ga DABCO −20 5ga 76 92:8 (94:6) 
[a] Yield obtained after flash chromatography of the endo-product. [b] Determined by chiral HPLC analysis (Daicel, Chiralpak AS) of the crude product. 
More than 98:2 endo:exo ratio by 1H NMR spectroscopy. In brackets the er of the purified product 5.  
 
Table 3. 1,3-DC of glycine methyl iminoesters 4 and α−substituted methyl iminoesters 6-8 with assorted dipolarophiles, catalyzed by 5 mol-% of (Sa,R,R)-
3:AgClO4 complex.  
Entry Ar R Iminoester Base Dipolarophile T [ºC] Structure Cycloadduct 
No 
Yield 
[%][a] 
erendo[b][c] 
 
1 
 
Ph 
 
H 
 
4aa 
 
DABCO 
 
NMM[d] 
 
20 
N
H
Ph CO2Me
NO O
 
 
9aa 
 
80 
 
>99:1 (>99:1) 
 10
 
2 
 
Ph 
 
H 
 
4aa 
 
Et3N 
 
NEM[d] 
 
0 
N
H
Ph CO2Me
NO O
Et
 
 
10aa 
 
78 
 
94:6 (94:6) 
3 
4 
Ph 
Ph 
H 
H 
4aa 
4aa 
Et3N 
DABCO 
Diisopropyl fumarate 
Diisobutyl maleate 
−20 
0 N
H
R2O2C
Ph CO2Me
CO2R2
 
11aa 
12aa 
81 
79 
91:9 (91:9) 
91:9 (91:9) 
5 
6 
7 
Ph 
2-Me-C6H4 
4-Me-C6H4 
H 
H 
H 
4aa 
4ba 
4da 
Et3N 
Et3N  
Et3N 
Chalcone 
Chalcone  
Chalcone 
−20 
−20 
−20 
 
N
H
Ar CO2Me
Ph
O
Ph
 
13aa 
14ba 
14da 
80 
70 
75 
>99:1 (>91:1) 
90:10 
(99:1)[e] 
97:3 (97:3) 
8 2-Naphthyl H 4ga Et3N Cyclopent-2-enone −20 
N
H
2-Naph CO2Me
O
 
15ga 72 96:4 (97:3) 
9 
10 
Ph 
Ph 
Me 
Me 
6aa 
6aa 
Et3N 
DABCO 
tert-Butyl acrylate 
tert-Butyl acrylate 
−20 
0 NH
tBuO2C
Ph
CO2Me  
16aa 
16aa 
78 
77 
97:3 (97:3) 
94:6 (94:6) 
11 Ph Bn 7aa Et3N tert-Butyl acrylate −20[f] 
N
H
tBuO2C
Ph
CO2Me
Bn
 
17aa 77 99:1 (99:1) 
12 
13 
2-Thienyl 
2-Thienyl 
Me 
Me 
6ha 
6ha 
Et3N 
DABCO 
tert-Butyl acrylate 
tert-Butyl acrylate 
−20 
−20 N
H
tBuO2C
CO2MeS  
18ha 
18ha 
78 
79 
96:4 (96:4) 
94:6 (94:6) 
14 
15 
2-Thienyl 
2-Thienyl 
iBu 
iBu 
8ha 
8ha 
Et3N 
DABCO 
tert-Butyl acrylate 
tert-Butyl acrylate 
−20[f] 
−20[f] N
H
tBuO2C
CO2MeS  
19ha 
19ha 
70 
68 
91:9 (91:9) 
78:22 (78:22) 
16 
17 
Ph 
Ph 
Me 
Me 
6aa 
6aa 
Et3N 
Et3N 
NMM 
NMM 
0[e] 
−20[f] 
N
H
Ph
CO2Me
NO O
 
20aa 
20aa 
80 
74 
78:22 (78:22) 
86:14 (86:14) 
18 
19 
Ph 
Ph 
Bn 
Bn 
7aa 
7aa 
Et3N 
Et3N 
NMM 
NMM 
0 
−20[f] 
N
H
Ph
CO2Me
NO O
Bn
 
21aa 
21aa 
71 
80 
88:12 (95:5) 
75:25 (75:25) 
20 Ph Me 6aa Et3N Chalcone −20 
N
H
Ph CO2Me
Ph
O
Ph
 
22aa 81 90:10 (90:10) 
21 2-Naphthyl Me 6ga Et3N Pent-3-enone −20 
N
H
2-Naph
CO2Me
O
 
23ga 71 84:16 (84:16) 
[a] Yield obtained after flash chromatography of the endo-product. [b] Determined by chiral HPLC analysis (see, experimental part) of the crude product. 
More than 98:2 endo:exo ratio by 1H NMR spectroscopy. [c] In brackets the er of the purified endo-cycloadduct. [d] The reaction took 6 h. [e] A 70:30 
endo:exo mixture was obtained in the crude product. [f] The reaction took 48 h. 
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Scheme 5. 
 
 
Figure 4. Chief geometric features saddle relative energies (in kcal/mol) of the four transition structures associated with the first step in the 
reaction between t-butyl acrylate and complex II formed by (Sa)-Monophos 1 and imine 4aa. Bond distances and angles are given in Å and 
deg, respectively. These fully optimized structures were computed at the B3LYP/LanL2DZ&6-31G* level. The energies were computed at 
the B3LYP/ LanL2DZ &6-31G*+ΔZPVE level of theory. 
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endo-(2S,4S,5R)-27
tBu tBu
tBu
tButBu
 
Figure 5. Reaction coordinate associated with the reaction between tert-butyl acrylate and complex II. Bond distances and angles are given 
in Å and deg, respectively. The relative energies have been computed at the B3LYP/LanL2DZ&6-31G*+ΔZPVE level of theory. 
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